申请人:Hoffmann-La Roche Inc.
公开号:US05137920A1
公开(公告)日:1992-08-11
Compunds having the formula ##STR1## wherein each of R.sup.1 and R.sup.2 individually is hydrogen, lower alkyl, or lower alkenyl, R.sup.3 is hydrogen, halogen or lower alkyl, Q is alkylene with 2 to 11 carbon atoms and at least 2 carbon atoms between the two free valencies or alkenylene with 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and each of Y and Y' individually is a direct bond, the group R.sup.1 R.sup.2 --N--Q--CH.sub.2 -- is attached to the 3- or 4-position of ring A and the symbol R represents that the ring to which it is attached is unsubstituted or is substituted with at least one of halogen, trifluoromethyl, cyano, nitro, lower alkyl or lower alkoxy, and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties. In particular, they have a pronounced antifungal activity and can be used as medicaments, especially for the control or prevention of topical or systemic infections which are caused by pathogenic fungi.
具有以下式子的化合物:##STR1## 其中R.sup.1和R.sup.2各自为氢,低烷基或低烯基,R.sup.3为氢,卤素或低烷基,Q为具有2到11个碳原子并且两个自由价之间至少有2个碳原子的脂肪基或具有4到11个碳原子并且两个自由价之间至少有4个碳原子的烯基,Y和Y'各自为直接键,基团R.sup.1 R.sup.2 --N--Q--CH.sub.2 --连接到环A的3-或4-位置,符号R表示其连接的环未被取代或被卤素、三氟甲基、氰基、硝基、低烷基或低烷氧基中的至少一种所取代,其药学上可接受的酸盐具有有价值的药理作用。特别地,它们具有明显的抗真菌活性,可用作药物,特别是用于控制或预防由病原真菌引起的局部或全身感染。